Several studies have demonstrated increased CCL2 in the circulation and BAL fluid of IPF patients [38,39], and the correlation of serum CCL2 levels with the clinical course of IPF has also been demonstrated [39]. This evidence concerns the gene CCL2 and idiopathic pulmonary fibrosis.